Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Clinical studies on the radioimmunodetection of tumors containing alpha-fetoprotein

Journal Article · · Cancer; (United States)

This study reports the use of radiolabeled antibodies to alpha-fetoprotein for the detection and localization of hepatocellular and germ cell carcinomas. Twelve patients with histories of histologically-confirmed neoplasia received a total dose between 1.0 and 4.4 mCi of /sup 131/I-labeled goat IgG prepared against human alpha-fetoprotein. Total-body photoscans were taken with a gamma scintillation camera at various intervals after injection of the radioactive antibody. Computer subtraction of radioactive technetium background images from the antibody /sup 131/I scans permitted the visualization of all tumor sites known to be present in 4 patients with either primary hepatocellular cancer or metastatic germ cell carcinoma of the testis. Among 8 patients with diverse neoplasms not believed to contain alpha-fetoprotein, 5 of 19 tumor sites showed radioactive antibody accretion, although significantly less than in the patients with liver or testicular cancer. This investigation indicates that alpha-fetoprotein-containing tumors can be detected and localized in vivo by the method of radioimmunodetection.

Research Organization:
Univ. of Kentucky, Lexington
OSTI ID:
6443651
Journal Information:
Cancer; (United States), Journal Name: Cancer; (United States) Vol. 45:10; ISSN CANCA
Country of Publication:
United States
Language:
English